Delivery Order SPE2DR25D2006-SPE2DR26F57VP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,679.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 30, 2025, with performance completion targeted for December 31, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, indicating competitive selection through open procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,177.85 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes, with an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Durolane 60 mg/3 mL syringes with a ceiling value of $10,514.15. This non-competitive, firm fixed-price delivery order is set to be completed by December 11, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $19,866.96 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $10,443.67 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Durolane 60 mg/3 ml syringes. This is a firm fixed price, non-set-aside contract with a completion date of June 3, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to fulfill this requirement as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $30,233.45 for Durolane 60 mg/3 mL syringes on January 5, 2026, with completion expected by January 6, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,679.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price, non-competitive delivery order was executed on January 20, 2026, with an ultimate completion date of January 21, 2026. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,913.36 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on December 19, 2025, with an ultimate completion date of December 22, 2025. This firm fixed price, non-set-aside contract represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,506.50 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by September 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's larger...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57VPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $17,415.92 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by February 4, 2026, with performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competed on a full and open basis among qualified vendors. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medications, vaccines, syringes, and medical devices across multiple therapeutic domains. AmerisourceBergen, now operating under parent company Cencora, Inc., maintains a significant role in the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.4k | 2/2/26 |